arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Editas Medicine, Inc.

EDIT Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$2.71
▼ -9.4% Today
as of Jun 7, 07:13 ET
Last 30 days -11.44% Apr 28 → Jun 05
$2.37 $2.69 $3.01 $3.34 $3.66 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.97
High
$3.00
Low
$2.63
Volume
$2M
Avg Vol
$2M
Mkt Cap
$336M
P/E (TTM)
Beta
52w High
$4.54
52w Low
$1.66
Div Yield
Shares Out
$98M

Overview

52-week range
$1.66
$4.54
36% of range
Avg surprise (last 2)
+14.5%
Avg reaction (last 2)
+3.8%
100% positive
Latest IV / EM
200%
EM ±27.7% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.82$-0.68$-0.54$-0.40$-0.26 Actual $-0.56Actual $-0.55Actual $-0.76Actual $-0.82Actual $-0.75Actual $-0.43Est $-0.51Actual $-0.63Actual $-0.28Actual $-0.26Est $-0.30 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-76M$-64M$-51M$-39M$-26M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.26 $-0.30 +13.3% +39.5% +1.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.28 financials
Mon Jun 30, 2025Jun 2025 $-0.63 financials
Mon May 12, 2025Mar/2025 $-0.43 $-0.51 +15.7% +6.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.75 financials
Sun Jun 30, 2024Jun 2024 $-0.82 financials
Sun Mar 31, 2024Mar 2024 $-0.76 financials
Sat Sep 30, 2023Sep 2023 $-0.55 financials
Fri Jun 30, 2023Jun 2023 $-0.56 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-25M$-25M$-52M$-76M$-66M$-72M
Net income$-25M$-25M$-53M$-76M$-62M$-68M
EPS (diluted)$-0.26$-0.28$-0.63$-0.92$-0.75$-0.82

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$124M$147M$166M$139M$139M$132M$96M$64M
Inventory
Total current assets$128M$164M$177M$183M$225M$289M$271M$286M
Total assets$149M$187M$202M$211M$264M$342M$328M$385M
Long-term debt$47M$54M$54M$52M$50M$52M
Total liabilities$145M$159M$188M$191M$201M$207M$152M$153M
Total equity$4M$27M$13M$19M$62M$134M$176M$232M

Implied volatility — last 90 days

194%197%199%202%204% Jun 07 — IV 200% · EM ±27.7%

Sector peers